Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Op. & Scientific Officer
-
Stock Symbol
-
CPRX on Nasdaq
Steve Miller - trading volume in the past year for Catalyst Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Restricted Stock Units |
1.84M |
$7.37M |
$4.01 |
Dec 9, 2024 |
Direct |
Common Stock |
|
Common stock, par value $0.001 per share |
922K |
$3.7M |
$4.01 |
Dec 13, 2024 |
Direct |
|
|
Options to purchase common stock |
1.55M |
|
|
Dec 13, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.